SEC Form 4 · accession 0001144204-15-002868

ACHILLION PHARMACEUTICALS INC · ACHN

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners

10% Owner

Other

10% Owner

Period of report

Jul 15, 2013

Accepted (ET)

Jan 20, 2015 · 6:10 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001070336

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock, $0.001 par value^F1,F2	Sep 16, 2013	S	91,801	$7.5262	D	4,867,617	D
Common Stock, $0.001 par value^F1,F2	Sep 17, 2013	S	77,600	$7.4226	D	4,959,418	D
Common Stock, $0.001 par value^F1,F2	Sep 18, 2013	S	2,328	$7.48	D	5,037,018	D
Common Stock, $0.001 par value^F1,F2	Sep 20, 2013	S	26,539	$7.4035	D	5,039,346	D
Common Stock, $0.001 par value^F1,F2	Sep 23, 2013	S	5,665	$7.415	D	5,065,885	D
Common Stock, $0.001 par value^F1,F2	Sep 23, 2013	S	27,783	$7.4192	D	5,071,550	D
Common Stock, $0.001 par value^F1,F2	Sep 24, 2013	S	77,600	$7.30	D	5,099,333	D
Common Stock, $0.001 par value^F1,F2	Sep 24, 2013	S	4,424	$7.33	D	5,176,933	D
Common Stock, $0.001 par value^F1,F2	Sep 24, 2013	S	49,354	$7.345	D	5,181,357	D
Common Stock, $0.001 par value^F1,F2	Sep 24, 2013	S	50,051	$7.38	D	5,230,711	D
Common Stock, $0.001 par value^F1,F2	Sep 25, 2013	S	135,800	$7.26	D	5,280,762	D
Common Stock, $0.001 par value^F1,F2	Sep 27, 2013	P	200,000	$4.00	A	5,416,562	D
Common Stock, $0.001 par value^F1,F2	Sep 27, 2013	P	400,000	$4.00	A	5,216,562	D
Common Stock, $0.001 par value^F1,F2	Sep 30, 2013	P	1,552,000	$3.50	A	4,816,562	D

No Table II lines on this filing.

F1The reported securities are owned by RA Capital Healthcare Fund, L.P. (the "Fund"). RA Capital Management, LLC (the "Adviser") is the general partner of the Fund, and Peter Kolchinsky is the sole manager of the Adviser. The Adviser and Mr. Kolchinsky disclaim beneficial ownership of the reported securities in reliance on Rule 16a-1(a)(1)(v) and (vii), respectively, and therefore disclaim any obligation to report ownership of the reported securities other than on behalf of the Fund. The filing of this Form 4 shall not be construed as an admission that either the Adviser or Mr. Kolchinsky is or was, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the beneficial owner of any of the securities reported herein. The number of shares reported in Column 5 of Table I and the number of options reported in Column 9 of Table II reflect the number of shares or options, as applicable, beneficially owned by the Fund as of the filing date of this Form 4.
F2On July 15, 2013, the Fund became a beneficial owner of more than ten percent of the outstanding shares the issuer's common stock and therefore became subject to Section 16 of the Securities Exchange Act of 1934. On September 23, 2014, the Fund ceased to be a beneficial owner of more than ten percent of the outstanding shares the issuer's common stock and ceased to be subject to Section 16.